201 related articles for article (PubMed ID: 17318876)
1. Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Williams KM; Higman MA; Chen AR; Schwartz CL; Wharam M; Colombani P; Arceci RJ
Pediatr Blood Cancer; 2008 Mar; 50(3):667-70. PubMed ID: 17318876
[TBL] [Abstract][Full Text] [Related]
2. A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Mittal S; Milner BJ; Johnston PW; Culligan DJ
Eur J Haematol; 2006 Jun; 76(6):531-4. PubMed ID: 16548918
[TBL] [Abstract][Full Text] [Related]
3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
4. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
[TBL] [Abstract][Full Text] [Related]
5. Successful allogeneic stem cell transplantation for Lennert lymphoma.
Uni M; Yoshimi A; Nakamura F; Takazawa Y; Fukayama M; Kurokawa M
Ann Hematol; 2013 Jun; 92(6):859-60. PubMed ID: 23224245
[No Abstract] [Full Text] [Related]
6. Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Kontny U; Boppana S; Jung A; Goebel H; Strahm B; Peters A; Dormann S; Werner M; Bader P; Fisch P; Niemeyer C
Haematologica; 2005 Nov; 90 Suppl():ECR27. PubMed ID: 16266918
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
Bishton MJ; Haynes AP
Br J Haematol; 2007 Jan; 136(1):111-3. PubMed ID: 17116129
[TBL] [Abstract][Full Text] [Related]
8. Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Fetscher S; Lübbert M; Kanz L; Behringer D; Finke J; Mertelsmann R; Lange W
Bone Marrow Transplant; 1997 Mar; 19(5):527-8. PubMed ID: 9052926
[TBL] [Abstract][Full Text] [Related]
9. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
[TBL] [Abstract][Full Text] [Related]
10. Pseudo-bowel obstruction due to varicella zoster virus infection after autologous stem cell transplantation.
Precupanu CM; Girodet J; Mariani P; Zanni M; Mathiot C; Escande MC; Brault P; Decaudin D
Am J Hematol; 2009 Feb; 84(2):127-8. PubMed ID: 19127592
[No Abstract] [Full Text] [Related]
11. Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.
Eckrich MJ; Domm J; Ho R; Whitlock JA; Frangoul H
Pediatr Blood Cancer; 2009 Dec; 53(7):1327-8. PubMed ID: 19760777
[TBL] [Abstract][Full Text] [Related]
12. Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient.
Lones MA; Kirov I; Said JW; Shintaku IP; Neudorf S
Bone Marrow Transplant; 2000 Nov; 26(9):1021-4. PubMed ID: 11100284
[TBL] [Abstract][Full Text] [Related]
13. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
[TBL] [Abstract][Full Text] [Related]
14. Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma.
Scheid C; Pettengell R; Ghielmini M; Radford JA; Morgenstern GR; Stern PL; Crowther D
Bone Marrow Transplant; 1995 Jun; 15(6):901-6. PubMed ID: 7581089
[TBL] [Abstract][Full Text] [Related]
15. [EBV-associated B-cell lymphoproliferative disorder of the elderly successfully treated with autologous peripheral blood stem cell transplantation and locoregional radiotherapy].
Sugino N; Nakamura C; Fujii S; Matsui Y; Kaneko H; Watanabe M; Miura Y; Wakasa T; Tsudo M
Rinsho Ketsueki; 2011 Mar; 52(3):129-35. PubMed ID: 21471700
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
[TBL] [Abstract][Full Text] [Related]
17. [Management of diffuse large B-cell lymphoma in the rituximab era].
Kinoshita T
Rinsho Ketsueki; 2009 Oct; 50(10):1342-50. PubMed ID: 19915341
[No Abstract] [Full Text] [Related]
18. Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.
Gil L; Kozlowska-Skrzypczak M; Mol A; Poplawski D; Styczynski J; Komarnicki M
Bone Marrow Transplant; 2009 Jan; 43(2):121-6. PubMed ID: 18794866
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.
Davidson KL; Devaney MB; Tighe JE; Rogers SY; Dunlop DJ; Mackie MJ; Thomas RV; Johnson PR;
Haematologica; 2003 Dec; 88(12):1366-71. PubMed ID: 14687989
[TBL] [Abstract][Full Text] [Related]
20. Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders.
Komrokji RS; Oliva JL; Zand M; Felgar R; Abboud CN
Am J Hematol; 2005 Jul; 79(3):211-5. PubMed ID: 15981226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]